Lerodalcibep Matches Evolocumab in LDL-C Reduction for HoFH: Lancet Dr. Shravani Dali1 Feb 2025 3:15 AMResearchers have found in Phase 3 LIBerate-HoFH trial that Lerodalcibep, a third-generation PCSK9 inhibitor, showed similar efficacy to evolocumab in...
Early Adult LDL-C and Non-HDL-C Levels Strongly Predict Later ASCVD Risk, suggests study Dr Riya Dave6 Sept 2024 3:00 AMResearchers found that a single measurement of low-density lipoprotein cholesterol (LDL-C) or non-high-density lipoprotein cholesterol (non-HDL-C), if...
High-Intensity Statin Therapy Shows No Diabetes Difference for CAD Patients, LDL-C Impacts Outcome: LODESTAR Trial Analysis Medha Baranwal23 Aug 2024 2:45 AMKorea: In a recent post-hoc analysis of the LODESTAR randomized clinical trial, researchers found that high-intensity statin therapy for patients with...
High Apolipoprotein B- Potential Risk Factor for CVD: Latest Indian Experience MD Brand Connect30 July 2024 6:57 AMElevated levels of apolipoprotein B is a potential risk factor for cardiovascular disease (CVD) among Indians, a recent study has reported. The...
Primary-hypercholesterolemia may increase risk of hepatic complications in general population: Study Dr Riya Dave25 Jun 2024 2:30 PMResearchers have found that hypobetalipoproteinemia (HBL), characterized by permanently low levels of low-density lipoprotein-cholesterol (LDL-C),...
Control of Anthropometric Measures and Lipids may improve Gout Outcomes Dr Riya Dave18 Dec 2023 12:30 PMA recent study, published in Rheumatic and Musculoskeletal Diseases, delved into the nuanced relationship between gout outcomes, lifestyle changes,...
Vitamin D supplementation beneficial in managing dyslipidemia Aditi14 Nov 2023 8:30 PMVitamin D supplementation benefits lipid profile and is beneficial as a dietary intervention for managing dyslipidemia, says Nima Radkhah and...
Medical Bulletin 2/August/2023 Isra Zaman2 Aug 2023 10:12 AMHere are the top medical news of the day:American College of Physicians’ updated guidance for colorectal cancer screening of asymptomatic adultsThe...
Statin treatment initiation shows age as a substantial independent predictor of LDL-C response Isra Zaman2 Aug 2023 3:45 AMA study of more than 80,000 persons found that age is a significant independent predictor of low-density lipoprotein cholesterol (LDL-C) response to...
FDA approves expanded use of inclisiran for primary hyperlipidemia Dr. Kamal Kant Kohli13 July 2023 4:30 AMThe US Food and Drug Administration has approved expanded use of inclisiran (Leqvio) for primary hyperlipidemia besides its existing indications of...
LDL Electronegativity- a novel determinant of mortality risk in ASCVD Aditi24 Jun 2023 4:00 AMSimon Kraler et al. and colleagues from the Center for Molecular Cardiology, University of Zurich, have highlighted that Reduced low-density...
In moderate CKD patients with apparent proteinuria, LDL-C levels < 70mg dL provide CV and renal benefits: JAHA Medha Baranwal4 Oct 2022 12:30 AMTaiwan: Statin use in patients with stage 3 chronic kidney disease having group has the lowest intracerebral hemorrhage risk, albeit a lower...
